Benedict Cross, PhD profile page

Ben is the Chief Technology Officer and Head of Platform at PhoreMost Ltd, a pre-clinical drug discovery company based in Cambridge, UK. He is a geneticist & biotechnologist and has pioneered the use of computationally engineered mini-proteins to enable new medicine development, including bivalent and monovalent degrader-based drugs. Ben has research expertise in proteostasis, functional genomics and chemical genetic screening and in 2014 founded the UKs first CRISPR-based functional genomics screening platform. He is the inventor of the GlueSEEKER platform at PhoreMost and has authored over 30 peer reviewed studies and patents working at the intersection of biology, drug discovery and data science. As a serial biotech platform builder, Ben has a particular proclivity for collaboration and for engineering business alliances across the life sciences sector.